MPD: List measures where strain C3H/HeJ is an outlier

List measures where C3H/HeJ is an outlier

Click on pulldowns below to see C3H/HeJ means with summary statistic tooltips.
Within each pulldown, the "up" and "down" triangles indicate when this strain is an outlier.
You can also download all phenotypes for this strain and sort by Z score in Excel.

Sort/ Pick	Data set	Procedure / Protocol	Treatment	Phenotype Measure / Variable (click to view)	Panel	No. of Strains	Sex	Age	Sample Size (Avg)	Year
Ackert1:11	Ackert1	DXA	(none)	bone mineral density (BMD) [g/cm²] BMD 25011 6mo 12mo 20mo	inbred	32	both		N=7	2008

Berndt2:14	Berndt2	plethysmography	methacholine	inspiratory phase [s] inspiratory 35114 saline 5 MCh 10 MCh 20 MCh response index	inbred	29	both	9-12wks	N=8	2010

Berndt2:21	Berndt2	plethysmography	methacholine	expiratory phase [s] expiratory 35121 saline 5 MCh 10 MCh 20 MCh response index	inbred	29	both	9-12wks	N=8	2010

Berndt2:28	Berndt2	plethysmography	methacholine	respiratory cycle [s] tot_respi 35128 saline 5 MCh 10 MCh 20 MCh response index	inbred	29	both	9-12wks	N=8	2010

Brown1:50	Brown1	open field test	(none)	total time in center square, 5 min test, day 1 [s] center_dur_d1_OFT 9450	inbred	14	both	10wks	N=13	2004

Brown1:51	Brown1	open field test	(none)	total center square entries, 5 min test, day 1 [n] center_ent_d1_OFT 9451	inbred	14	both	10wks	N=13	2004

CGDpheno1:70	CGDpheno1	metabolic panel	(none)	thyroxine (plasma T4) [µg/dL] T4 31870	inbred w/CC8	72	both	12wks	N=7	2009

Crabbe1:4	Crabbe1	balance beam	ethanol	missteps crossing 15.8mm wide balance beam [n] bal15 15404 dose (g/kg): control 1.0 1.2 1.4	inbred	8	both	8-16wks	N=3	2003

Crabbe2:14	Crabbe2	body temperature	diazepam	body temperature, 30 min post-injection [°C] temp_DZ 15514 baseline doses mg/kg: 2 4 8 16	inbred	15	m	6-7wks	N=8	1998

Crabbe3:10	Crabbe3	rotarod	ethanol	latency to fall, fixed speed 3 rpm rotarod [s] FS_3rpm_EtOH 15810 dose (g/kg): 1 2 3	inbred	9	both	9-17wks	N=4	2003

Crowley1:33	Crowley1	behavior observation	haloperidol	overt chewing movements, 15 min test [n] overtchew 39433 day: 0 30 60 120	inbred w/CC8	27	m	9-28wks	N=6	2012

Crowley1:41	Crowley1	behavior observation	haloperidol	jaw tremor duration, 15 min test [s] jawtremor 39441 day: 0 30 60 120	inbred w/CC8	27	m	9-28wks	N=6	2012

Donahue1:10	Donahue1	DXA	(none)	nose length (craniofacial) [mm] nose_length 11519	inbred w/CC7	29	both	15-16wks	N=9	2002

Donahue1:17	Donahue1	metabolic panel	(none)	thyroxine (serum T4) [µg/dL] thyroxine 11531	inbred w/CC7	29	both	15-16wks	N=9	2002

Donahue2:2	Donahue2	DXA	(none)	volumetric bone mineral density (vBMD), whole left femur [g/cm³] femur_vBMD 17202	inbred	10	both	16wks	N=10	2004

Donahue2:4	Donahue2	DXA	(none)	cross sectional volumetric bone mineral density (vBMD), right femur mid-diaphysis [g/cm³] femur_shaft_BMD 17204	inbred	10	both	16wks	N=10	2004

Donahue2:6	Donahue2	biomechanical test	(none)	maximum load on load-displacement curve [N] femur_peak_load 17206	inbred	10	both	16wks	N=10	2004

Donahue2:8	Donahue2	biomechanical test	(none)	load at specimen failure (break point) [N] femur_break_load 17208	inbred	10	both	16wks	N=10	2004

Donahue2:9	Donahue2	biomechanical test	(none)	load at 95% break load [N] femur_yield_load 17209	inbred	10	both	16wks	N=10	2004

Donahue2:17	Donahue2	computed tomography	(none)	cortical thickness of right femur, pQCT [mm] femur_thickness_R1 17217	inbred	10	both	16wks	N=10	2004

Donahue2:18	Donahue2	computed tomography	(none)	cortical thickness of right femur, µCT [mm] femur_thickness_R2 17218	inbred	10	both	16wks	N=10	2004

Donahue2:19	Donahue2	computed tomography	(none)	cortical thickness of left femur, pQCT [mm] femur_thickness_L 17219	inbred	10	both	16wks	N=10	2004

Donahue2:31	Donahue2	biomechanical test	(none)	estimated ultimate strength [N] ultimate_strength 17231	inbred	10	both	16wks	N=10	2004

Gupta1:8	Gupta1	organ dimensions	(none)	kidney planar surface area [mm²] area_kidney 39109 left right	inbred	8	both	postnatal d1	N=9	2011

Gupta1:12	Gupta1	renal function assay	(none)	urethral hydrostatic pressure at which dye is observed flowing [cm] pressure_urethra 39114	inbred	8	both	postnatal d1	N=9	2011

Hampton1:5	Hampton1	ECG	(none)	heart rate variability [n/min] HR_VAR 1705	inbred	17	both	9-12wks	N=8	2001

Hampton1:7	Hampton1	ECG	(none)	interval between peak of P-wave to Q-wave (PQ) [ms] PQ 1707	inbred	17	both	9-12wks	N=8	2001

Hawes1:9	Hawes1	slit lamp	(none)	corneal opacity, focal [frequency rate] cornea_focal 26709	inbred w/CC7	41	both	6-7wks	N=10	2008

Jaxpheno2:20	Jaxpheno2	organ weights	(none)	liver weight [g] liver 22720 age 8wks age 16wks	inbred	11	both		N=8	2006

Justice2:14	Justice2	complete blood count	(none)	neutrophil differential (NEUT; percentage of total WBC) [%] pctN 13214	inbred	16	both	12-16wks	N=12	2002

Justice2:15	Justice2	complete blood count	(none)	lymphocyte differential (LYM; percentage of total WBC) [%] pctL 13215	inbred	16	both	12-16wks	N=12	2002

Kliethermes1:44	Kliethermes1	hole board test	(none)	residual score from regression of object preference (count) on horizontal activity in object preference task to assess novelty seeking, 10 min test [score] regression_OP 59944	inbred	14	both	8wks	N=6	2006

Loos2:1	Loos2	home cage monitoring	(none)	cumulative number of activity bouts, over 3 days of testing, log10 transformed [log(n)] activity_num 54001 dark light	inbred w/CC7	11	m	8-12wks	N=40	2016

Loos2:42	Loos2	home cage monitoring	(none)	cumulative long movement number, over 3 days of testing, log10 transformed [log(n)] long_move_num 54042 dark light	inbred w/CC7	11	m	8-12wks	N=40	2016

Loos2:44	Loos2	home cage monitoring	(none)	cumulative long movement distance, over 3 days of testing, log10 transformed [log(cm)] long_move_dist 54044 dark light	inbred w/CC7	11	m	8-12wks	N=40	2016

Loos2:54	Loos2	home cage monitoring	(none)	cumulative number of long arrests, over 3 days of testing, log10 transformed [log(n)] long_arrest_num 54054 dark light	inbred w/CC7	11	m	8-12wks	N=40	2016

Loos2:75	Loos2	home cage monitoring	(none)	fraction of shelter visits (sheltering) with duration longer than long shelter visit threshold, over 3 days of testing, log10 transformed [log(ratio)] long_shelter_fraction 54075	inbred w/CC7	11	m	8-12wks	N=40	2016

Loos2:77	Loos2	home cage monitoring	(none)	cumulative number of short shelter visits (sheltering), over 3 days of testing, log10 transformed [log(n)] short_shelter_num 54077 dark light	inbred w/CC7	11	m	8-12wks	N=40	2016

Loos2:83	Loos2	home cage monitoring	(none)	cut-off value to separate short and intermediate shelter visits (sheltering), over 3 days of testing [log(s)] short_shelter_threshold 54083	inbred w/CC7	11	m	8-12wks	N=40	2016

Maurer1:57	Maurer1	ECG	atenolol, isoproterenol	area of QRS [ms*mV] QRSarea 33257 control atenolol 10mg isoprot 1mg isoprot 10mg	inbred	23	m	7-13wks	N=9	2009

Metten1:15	Metten1	behavior observation	ethanol	erratic gait, 3.0 g/kg i.p. [score] wobble_doseB 16515 10min after injection 30min after	inbred	9	both	8-11wks	N=4	2004

Metten2:6	Metten2	behavior observation	ethanol	latency to first handling-induced convulsions score used to calculate peak ethanol [h] peak_latency 19506	inbred	15	m	8-15wks	N=11	2005

Mitchell1:3	Mitchell1	go/no-go task	(none)	number of responses made during pre-cue period [n/s] precue_rate 37603	inbred	15	m	5-7wks	N=8	2010

Mogil1:5	Mogil1	nociception assay	(none)	number of abdominal constrictions induced with acetic acid (i.p.), 20 min [n] AC_AA 2205	inbred	11	m	6-18wks	N=6	2002

Moy1:4	Moy1	three chamber assay	(none)	time spent sniffing cage with stranger1 (a novel mouse), 10 min test [s] SnSTR1_soc 30104	inbred	17	m	6-7wks	N=22	2008

Moy1:21	Moy1	three chamber assay	(none)	time spent sniffing cage with stranger1 (former novel mouse), 10 min test [s] SnSTR1_nov 30121	inbred	17	m	6-7wks	N=22	2008

Moy1:22	Moy1	three chamber assay	(none)	time spent sniffing cage with novel stranger2 (a second novel mouse), 10 min test [s] SnSTR2_nov 30122	inbred	17	m	6-7wks	N=22	2008

Peters1:16	Peters1	complete blood count	(none)	basophil differential (percent of total WBC) [%] BASO 6216	inbred w/CC7	43	both	10wks	N=11	2001

Peters1:18	Peters1	complete blood count	(none)	calculated hemoglobin (HGB) [g/dL] cHGB 6218	inbred w/CC7	43	both	10wks	N=12	2001

Petkova1:6	Petkova1	immune cell quantification	(none)	lymphocyte differential (LYM; percentage of total WBC) [%] LYM 24206 6mo 12mo 18mo 24mo	inbred	32	both		N=8	2007

Petkova1:11	Petkova1	immune cell quantification	(none)	neutrophil differential (NEUT; percentage of total WBC) [%] NEUT 24211 6mo 12mo 18mo 24mo	inbred	32	both		N=7	2007

Petkova1:46	Petkova1	immune cell quantification	(none)	CD4 T cells, effector, as percentage of total CD4 T cells [%] CD4_effector 24246 6mo 12mo 18mo 24mo	inbred	32	both		N=8	2007

Petkova1:76	Petkova1	immune cell quantification	(none)	natural killer (NK) cells, as percentage of total lymphocytes [%] NK 24276 6mo 12mo 18mo 24mo	inbred	32	both		N=8	2007

Richfield1:21	Richfield1	open field test	(none)	short-term habituation, change in vertical activity over 45 min, day 3 [n/min] vert_short_habit 14521	inbred	15	m	7-9wks	N=7	2003

Schonfeld1:15	Schonfeld1	lipid profile	(none)	total cholesterol (plasma CHOL) [mg/dL] TC 32331	inbred	11	both	9-13wks	N=6	2005

Schonfeld1:17	Schonfeld1	lipid profile	(none)	cholesterol ester (plasma) [mg/dL] CE 32333	inbred	10	both	9-13wks	N=6	2005

Schonfeld1:19	Schonfeld1	lipid profile	(none)	phospholipids (plasma) [mg/dL] PL 32335	inbred	10	both	9-13wks	N=6	2005

Schulz1:9	Schulz1	ventilator	(none)	vital capacity [µL] VC 1609	inbred	7	both	12-14wks	N=15	2000

Schulz1:13	Schulz1	ventilator	(none)	respiratory system resistance with breathing rate of 130 per min (H₂O pressure) [cm/mL/s] R 1613	inbred	7	both	12-14wks	N=15	2000

Schulz1:14	Schulz1	ventilator	(none)	specific respiratory system resistance with breathing rate of 130 per min related to total lung capacity (H₂O pressure) [cm⋅s] sR 1614	inbred	7	both	12-14wks	N=15	2000

Threadgill1:12	Threadgill1	metabolic panel	acetaminophen	blood urea nitrogen (serum BUN) [mg/dL] BUN 19412 dose (mg/kg) control 100 200 300	inbred w/CC7	37	m	8-17wks	N=2	2005

Tordoff1:3	Tordoff1	bottle choice test	(none)	preference for NaCl (sodium chloride) solutions [%] NaCl_pref 6103 concentration (mM): 75 150 300 450	inbred	28	m	4-12wks	N=11	2001

Tordoff3:17	Tordoff3	bottle choice test	(none)	preference for NaLa (sodium lactate) solutions [%] NaLa_pref 10317 concentration (mM): 25 75 225	inbred w/CC7	40	both	12-14wks	N=10	2002

Wiltshire1:3	Wiltshire1	light-dark box	(none)	percent duration in light zone, 10 min [%] pct_light_LD 21403	inbred	26	both	12-14wks	N=5	2010

Xing1:21	Xing1	ECG	(none)	interval PR [ms] PR 24921 6mo 12mo 20mo	inbred	29	both		N=7	2008

Xing1:26	Xing1	ECG	(none)	interval QRS [ms] QRS 24926 6mo 12mo 20mo	inbred	29	both		N=7	2008

Xing1:31	Xing1	ECG	(none)	interval QT [ms] QT 24931 6mo 12mo 20mo	inbred	29	both		N=7	2008

Xing1:41	Xing1	ECG	(none)	interval ST [ms] ST 24941 6mo 12mo 20mo	inbred	29	both		N=7	2008

Yuan3:16	Yuan3	metabolic panel	(none)	calcium (serum Ca) [mg/dL] Ca 24416 6mo 12mo 18mo	inbred	32	both		N=7	2008

Yuan3:61	Yuan3	metabolic panel	(none)	dissolved-ionized carbon dioxide (CO₂) [mmol/L] CO2 24461 6mo 12mo 18mo	inbred	32	both		N=7	2008

Yuan3:76	Yuan3	metabolic panel	(none)	thyroxine (serum T4) [µg/dL] T4 24476 6mo 12mo 18mo	inbred	32	both		N=7	2008

List measures where C3H/HeJ is an outlier

Filter Table Results